The Substance Abuse and Mental Health Services Administration has released updated reports h
News
Latest
The House Ways and Means Health Subcommittee seeks input through Aug. 25 on how Congress can reduce legislative and regulatory burdens on Medicare providers.
The Centers for Medicare & Medicaid Services is accepting applications for 2017 hardship exceptions to the Quality Payment Program’s Advancing Care Information performance category.
The AHA’s Health Research & Educational Trust Aug.
The AHA’s Association for Community Health Improvement is accepting proposals for breakout sessions and posters for its 15th Annual National Conference.
The Food and Drug Administration yesterday announced it would pursue a strategic, new public health educa
The AHA will host its inaugural workforce conference, “Sustainable Health Care Delivery Through Strategic Workforce Development,” Oct. 25-26 in Chicago.
The Centers for Disease Control and Prevention and others are investigating an increase in reported cases of cyclosporiasis – an intestinal illness caused by the parasite Cyclospora cayet
The 2009 HITECH Act has spurred “large gains” in hospitals’ adoption of electronic health records, according to a study pu
The AHA’s Physician Leadership Forum Aug.
The Centers for Disease Control and Prevention and Food and Drug Administration are alerting health care providers to a nationwid
The average monthly premium for a basic Medicare Part D prescription drug plan in 2018 is estimated to be $33.50 per month – or approximately $1.20 less than the average premium in 2017 &ndas
Employment at the nation's hospitals rose by 0.14% in July to a seasonally adjusted 5,119,400 people, the Bureau of Labor Statistics
The Agency for Healthcare Research and Quality has released a map showing state trends and variation in opio
The Centers for Medicare & Medicaid Services last week extended Flo
Siemens has identified four vulnerabilities in molecular imaging products running Windows 7 that could allow an attacker to remotely execute arbitrary code, the Department of Homeland Security said
The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R.